Released: 04/06/2020 Expires: 12/31/2021 (subject to change)
CE for this activity will not be available after this date.
Overview Colorectal cancer is the third most common cancer and is the second leading cause of cancer-related death, yet it is the most preventable with screening. The overall survival rate is 65% but if it is diagnosed at an early stage 90% of patients survive. This activity will focus on colorectal cancer signs and symptoms, screening guidelines, and other management tools to aide with early diagnosis and better patient outcomes. CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the educational content completely:
Read the entire article.
Review all additional materials provided (handouts, posttest reviews, any other downloadable resources).
After completing all content, go to Steps to Receive Credit:
Complete the posttest
Submit the evaluation to receive full AANP CE/Rx credit.
Explain the importance of screening tests based on individualized care and recent guidelines
Describe early signs and symptoms of colorectal cancer
Discuss importance of family history and related cancers
Provide management for patients with survivorship issues
Speakers Laura Zitella, MS, RN, ACNP-BC, AOCN® Disclosure This program was planned in accordance with AANP CE Standards and Policies. Laura Zitella discloses the following affiliations: Advisory Board: • Daiichi Sankyo • Merck • Salix Pharmaceuticals
AANP planners have no relevant financial relationships to disclose Disclaimer Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. Additional Information For questions or more information concerning this online CE opportunity contact the AANP CE Center Manager at CECenter@aanp.org.
1 Contact Hour(s) of CE, 0.25 of which may be applied towards Pharmacology